Journal of Cancer Research and Therapeutics Close
 

Figure 3: Gemcitabine increased the 125I-induced apoptosis cells were treated with 125I, gemcitabine or concurrent 125I and gemcitabine. At a dose of 4 Gy, apoptosis analysis (a) and transferase-dUTP nick-end labeling assay (b) were used to analyze the cellular apoptosis. All experiments were performed in triplicate, and the data are presented as the mean ± standard deviation. The t-test was used for data analysis. *P < 0.05, **P < 0.01

Figure 3: Gemcitabine increased the <sup>125</sup>I-induced apoptosis cells were treated with <sup>125</sup>I, gemcitabine or concurrent <sup>125</sup>I and gemcitabine. At a dose of 4 Gy, apoptosis analysis (a) and transferase-dUTP nick-end labeling assay (b) were used to analyze the cellular apoptosis. All experiments were performed in triplicate, and the data are presented as the mean ± standard deviation. The <i>t</i>-test was used for data analysis. *<i>P</i> < 0.05, **<i>P</i> < 0.01